Christina Valdez, PA
Physician Assistant · Hamilton, OHNPI 1477184067
Payments from drug & device makers
Across 910 payments — averaging $21.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$7K
- Gilead$3K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$2K
- Takeda Pharmaceuticals U.S.A., Inc.$1K
- Bristol Myers Squibb$873
- Madrigal Pharmaceuticals$736
- plus $6K from 20 others
What the payments were for
- Consulting fees$1,6508%
- Speaking & faculty fees$1,3507%
- Travel & lodging$6123%
- Food & beverage$16,00781%
- Education$380%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 275 | $7,111 |
| Gilead | 44 | $2,653 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 130 | $1,504 |
| Takeda Pharmaceuticals U.S.A., Inc. | 53 | $1,167 |
| Bristol Myers Squibb | 87 | $873 |
| Madrigal Pharmaceuticals | 12 | $736 |
| Sanofi | 49 | $710 |
| Johnson & Johnson | 36 | $605 |
| E.r. Squibb & Sons, L.L.C. | 6 | $603 |
| QOL Medical, LLC | 26 | $546 |
| Aimmune Therapeutics, Inc. | 46 | $536 |
| Nestle Healthcare Nutrition Inc. | 38 | $418 |
| Phathom Pharmaceuticals, Inc. | 10 | $378 |
| Ardelyx, Inc. | 20 | $371 |
| Redhill Biopharma Inc. | 21 | $308 |
| Evoke Pharma, Inc. | 17 | $279 |
| Regeneron Healthcare Solutions, Inc. | 12 | $236 |
| Novo Nordisk | 4 | $178 |
| Ironwood Pharmaceuticals, Inc | 5 | $90 |
| Medtronic | 3 | $88 |
| Pfizer | 4 | $73 |
| Merck | 4 | $57 |
| Intercept Pharmaceuticals, Inc. | 3 | $51 |
| Ferring Pharmaceuticals Inc. | 2 | $43 |
| Braintree Laboratories, Inc. | 2 | $30 |
| Alnylam Pharmaceuticals Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$19,657 in reported general payments places this provider in the 95th percentile of 4,098 physician assistant providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MavyretGlecaprevir/Pibrentasvir | 13 | $170,116 |
| XifaxanRifaximin | 48 | $161,963 |
| LinzessLinaclotide | 79 | $76,362 |
| RezdiffraResmetirom | 19 | $75,848 |
| CreonLipase/Protease/Amylase | 21 | $50,527 |
| IbsrelaTenapanor Hcl | 11 | $19,154 |
| VemlidyTenofovir Alafenamide | 11 | $15,596 |
| MovantikNaloxegol Oxalate | 15 | $13,664 |
| Sucralfate | 41 | $7,934 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 77 | $4,773 |
| Pantoprazole Sodium | 418 | $4,678 |
| SutabSod Sulf/Pot Chloride/Mag Sulf | 15 | $2,440 |
| Omeprazole | 94 | $1,756 |
| Colestipol Hcl | 21 | $1,626 |
| Budesonide DrBudesonide | 11 | $1,175 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieMavyret, Linzess, Creon | $7,111 | $297,006113 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan | $1,504 | $161,96348 claims |
| Madrigal PharmaceuticalsRezdiffra | $736 | $75,84819 claims |
| Ardelyx, Inc.Ibsrela | $371 | $19,15411 claims |
| GileadVemlidy | $2,653 | $15,59611 claims |
| Redhill Biopharma Inc.Movantik | $308 | $13,66415 claims |
| Braintree Laboratories, Inc.Sutab | $30 | $2,44015 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,098 physician assistant providers in Ohio.
Other physician assistant in Hamilton
- Steven WurzelbacherCincinnati$309K
- Emily AnkromDayton$192K
- Amanda MaggartWorthington$164K
- Megan SevillaMayfield Heights$132K
- Erin StrculaBelpre$106K
- Natalie WalkupSylvania$105K
- Sarah LaubNew Albany$100K
- Jessica RhominskiCanal Winchester$78K
- Alan OdonnellCincinnati$71K
- Brook GramBeloit$52K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.